AURORA, Colo. (Sept. 3, 2020) - A new study led by researchers from the University of Colorado School of Medicine compares adolescent siblings to determine the impact of early and frequent use of marijuana on cognitive function.
This study, published in the journal Addiction, contrasts with previous studies by finding that moderate adolescent cannabis use may have adverse effects that cannot be explained by the genetic or environmental factors that siblings may have in common.
"We wanted to expand our understanding of whether cannabis use is related to lower cognitive functioning," said lead author Jarrod M. Ellingson, PhD, assistant professor of psychiatry at the CU School of Medicine. "There's a large body of evidence that cannabis use is linked to cognitive functioning, but we know that cannabis use is not isolated from other important risk factors. That was the primary motivation behind this study, in which we compared siblings to account for many of these risk factors."
Such possibilities include environmental risk factors, such as peer group influence, parental behavior, and socioeconomic status. In addition, by designing the study to look at siblings, researchers could consider whether genetic factors explain a shared risk for worse cognitive functioning and earlier or heavier cannabis use.
With this study, Ellingson and his colleagues were able to establish comparisons between siblings and then determine that differential levels of cannabis use were related to poorer cognitive functioning, particularly verbal memory.
The study participants were 1,192 adolescents from 596 families. They were primarily male - 64 percent - and racially and ethnically diverse, with non-Hispanic whites accounting for 45 percent. The families were from metro Denver and San Diego. Drug use was assessed through clinical interviews and cognitive abilities were analyzed through a battery of neuropsychological tests. Two waves of data were collected. The first wave was from participants with an average age of 17 from 2001-2006; the second wave was collected from 2008-2013, with an average participant age of 24.
"More work needs to be done to determine how cannabis use is related to cognitive functioning and we hope that our study can help inform future study designs," Ellingson said. "These studies are particularly important because cannabis is becoming more potent and more accessible as states legalize its recreational use."
In the article, Ellingson and his co-authors: "Due to changes in the legality of recreational and medical cannabis and widespread access in many states, valid empirical data must be available to inform policy and public health decisions, including how cannabis use may affect the developing brain."
Eleven co-authors are listed on the article, including senior author Christian J. Hopfer, MD, professor of psychiatry at CU School of Medicine. The DOI for the paper in the journal Addiction is 10.1111/add.15207.
The research was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R01DA035804, and by the National Institute on Alcohol Abuse and Alcoholism under Award Number K23AA026635. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About the University of Colorado School of Medicine
Faculty at the University of Colorado School of Medicine work to advance science and improve care. These faculty members include physicians, educators and scientists at UCHealth University of Colorado Hospital, Children's Hospital Colorado, Denver Health, National Jewish Health, and the Veterans Affairs Eastern Colorado Health Care System. The school is located on the Anschutz Medical Campus, one of four campuses in the University of Colorado system.